Advertisement

Topics

Probiodrug AG Company Profile

03:39 EDT 19th September 2018 | BioPortfolio

Probiodrug AG was established in 1997 as a spin off of the "Hans-Knöll-Institut für Wirkstoffforschung". Probiodrug is a wholly privately owned science driven drug development company, founded by Dr.'s. Hans-Ulrich Demuth and Konrad Glund, biochemists by education. The company is financed through venture capital and silent partnerships and successfully acquired R&D grants. The scientific advisory board is composed of international experts in fields relevant to the company's core business. Probiodrug's core competence is drug development based on target evaluation. Targets are serine and cysteine proteases, among them dipeptidyl peptidases I, IV and prolyl endopeptidase. DP IV is an ubiquitous enzyme which plays a key role in gastrointestinal peptide hormone regulation and in immune response (CD26) providing new therapeutic targets for metabolic disorders including diabetes and obesity as well immune diseases. Modulation of prolyl endopeptidase is a target for treatment of neuronal disorders as dementia. Based on the knowledge of pathophysiological mechanisms, specific and selective inhibitors of regulatory proteases have been identified as lead compounds for a target-orientated, rational drug design. probiodrug´s task is to develop new potential drug candidates from the in vitro characterization through preclinical studies up to a clinical proof of concept in man as an appropriate stage for licensing to the pharmaceutical industry.

Location

Weinbergweg 22
Halle/Saale
D-06120
Germany

Contact

Phone: 49-345-5559900
Fax: 49-345-5559901
Email: info@probiodrug.de


News Articles [26 Associated News Articles listed on BioPortfolio]

Probiodrug (PBD-NA): Positive read-across from -2-

DJ Probiodrug (PBD-NA): Positive read-across from BAN2401 Phase II data Dow Jones received a payment from EQS/DGAP to publish this press release. goetzpartners securities Limited Probiodrug (PBD-N...

Probiodrug (PBD) - Emerging details of PQ912 late-stage development

Edison Investment Research - Pharmaceutical & healthcare - Probiodrug: The highlight of Probiodrug’s FY17 results presentation was the rather detailed introduction of the Phase IIb development p...

Probiodrug AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

Probiodrug AG / Preliminary announcement on the disclosure of financial statements 27.03.2018 / 07:00 Preliminary announcement of the publication of financial reports according to Articles 114, 115, ...

ProBiodrug Aktie: Was ist hier los?

Nach einer alles andere als guten Performance in diesem Jahr kann die ProBiodrug Aktie seit dem Start der neuen Woche deutlich an Terrain gewinnen. Unter hohen Umsätzen schießt der Aktienkurs des U....

DGAP-DD: Probiodrug AG (deutsch)

DGAP-DD: Probiodrug AG deutsch Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen 23.05.2018 / 16....

DGAP-AFR: Probiodrug AG: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß § 114, 115, 117 WpHG

Dow Jones hat von EQS/DGAP eine Zahlung für die Verbreitung dieser Pressemitteilung über sein Netzwerk erhalten. DGAP Vorabbekanntmachung Finanzberichte: Probiodrug AG / Vorabbekanntmachung über di...

DGAP-DD: Probiodrug AG english

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 23.05.2018 / 16:30 The issuer is solely respon...

Management tracks: Probiodrug, Alder

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

Probiodrug AG

Probiodrug AG was established in 1997 as a spin off of the "Hans-Knöll-Institut für Wirkstoffforschung". Probiodrug is a wholly privately owned science driven drug development company, founded by Dr...

More Information about "Probiodrug AG" on BioPortfolio

We have published hundreds of Probiodrug AG news stories on BioPortfolio along with dozens of Probiodrug AG Clinical Trials and PubMed Articles about Probiodrug AG for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Probiodrug AG Companies in our database. You can also find out about relevant Probiodrug AG Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record